Fig. 3From: Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogsIn vitro stability studies in human serum (24 h, 37 °C) as analyzed by analytical RP-HPLC (10 → 30% MeCN in H2O + 0.1% TFA in 5 min, 30 → 60% MeCN in H2O + 0.1% TFA in 5 min)Back to article page